CytomX Therapeutics, Inc.

Q3 2024 13F Holders

Symbol
CTMX
CUSIP
23284F105
Type
Equity
Class
COM
Num filings
74
Total reported value, excl. options
$60.4 M
Manager Report Date Value ($000) Shares Option Type